Zobrazeno 1 - 7
of 7
pro vyhledávání: '"N M Glushchenko"'
Publikováno v:
Experimental Oncology. 44
To evaluate the prognostic significance of a panel of biomarkers for the identification of a highly malignant molecular subtype of endometrioid carcinoma of the endometrium (ECE).The expression of a number of markers (CD24, CD44, E2F1, FOXP3, Her2/ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcc84105039c7469755aa19861c44c70
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-3.18513
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-3.18513
Autor:
N M Glushchenko, Miriam Mints, Vasyl F. Chekhun, N Yu Lukianova, L G Buchynska, Elena Kashuba, N P Iurchenko, O V Brieieva
Publikováno v:
Experimental Oncology. 40:303-308
Background: Recent studies allow to consider the mitochondrial ribosomal protein S18-2 (MRPS18-2, S18-2) as a potential oncoprotein, which suggests the need for further characterization of its expression in tumors of different genesis including breas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e93613ec5273993591b720ee4801abbd
https://doi.org/10.31768/2312-8852.2018.40(4):303-308
https://doi.org/10.31768/2312-8852.2018.40(4):303-308
Publikováno v:
Experimental oncology. 42(4)
BACKGROUND Prognosis of the course of tumor progression is one of urgent problems of clinical oncology. A relevant specificity of endometrial cancer is its clinical polymorphism within the same histological type of the disease. The search for molecul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6cbc79749fb5011e9345f5d036d1aac
https://pubmed.ncbi.nlm.nih.gov/33355863
https://pubmed.ncbi.nlm.nih.gov/33355863
Publikováno v:
Experimental Oncology. 39:312-318
Aim: To determine the peculiarities of expression of a number of proteins-regulators of the cell cycle in endometrial cancer (EC) cells in patients with a family history of oncological pathologies. Patients and Methods: 95 EC patients (stage І–І
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::850455b891642ca78a83b5e6881cc202
https://doi.org/10.31768/2312-8852.2017.39(4):312-318
https://doi.org/10.31768/2312-8852.2017.39(4):312-318
Autor:
L G, Buchynska, N P, Iurchenko, E V, Kashuba, O V, Brieieva, N M, Glushchenko, M, Mints, N Yu, Lukianova, V F, Chekhun
Publikováno v:
Experimental oncology. 40(4)
Recent studies allow to consider the mitochondrial ribosomal protein S18-2 (MRPS18-2, S18-2) as a potential oncoprotein, which suggests the need for further characterization of its expression in tumors of different genesis including breast cancer (BC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a19c6a1a392fb916a6ada33d799dcd2e
https://pubmed.ncbi.nlm.nih.gov/30593750
https://pubmed.ncbi.nlm.nih.gov/30593750
Publikováno v:
Experimental oncology. 39(4)
To determine the peculiarities of expression of a number of proteins-regulators of the cell cycle in endometrial cancer (EC) cells in patients with a family history of oncological pathologies.95 EC patients (stage І-ІІ) were included into the stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::113dbda6d6ee8d7fa68134be9ce5db0e
https://pubmed.ncbi.nlm.nih.gov/29284773
https://pubmed.ncbi.nlm.nih.gov/29284773
Publikováno v:
Experimental oncology. 36(4)
To study the tumor microenvironment (CD4(+), CD8(+) and FOXP3(+) lymphocytes) and FOXP3 expression by tumor cells and correlation of studied parameters with clinical and morphological characteristics of endometrial adenocarcinomas.Tumor samples from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e5df03c07dbcb0cce64a5b95148921ca
https://pubmed.ncbi.nlm.nih.gov/25537221
https://pubmed.ncbi.nlm.nih.gov/25537221